Skip to Content

SG 332 (Nevirapine extended-release 100 mg)

Pill with imprint SG 332 is Yellow, Round and has been identified as Nevirapine extended-release 100 mg. It is supplied by ScieGen Pharmaceuticals Inc..

Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for SG 332

Nevirapine extended-release

Imprint:
SG 332
Strength:
100 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
ScieGen Pharmaceuticals Inc.
National Drug Code (NDC):
50228-0332

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide